Evidence map›Paper›PMID 42263037›Full record

ArticleCardiorenal medicine2026

Comparative Prognostic Assessment of European Kidney Function Consortium Equations for Mortality Prediction: A Population-Based Cohort Study.

Sitong Chen, Jinjing Shi, Iokfai Cheang, Gengmin Liang, Qiang Qu, Ziqi Chen, Huaxin Yuan, Yiyang Fu, Shengen Liao, Xinli Li

Abstract readComparative Study
In one paragraph

Article in Cardiorenal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sitong ChenState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Jinjing ShiState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Iokfai CheangState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Gengmin LiangState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Qiang QuState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Ziqi ChenState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Huaxin YuanState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Yiyang FuState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Shengen LiaoState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China, shengenliao@163.com.
Xinli LiState Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China, xinli3267@njmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe European Kidney Function Consortium (EKFC) has introduced equations for estimated glomerular filtration rate (eGFR) using serum creatinine (Cr) and cystatin C (Cys). While their diagnostic accuracy is established, their comparative prognostic value for long-term mortality in the general population is not well defined. This study compared the prognostic performance of three EKFC equations - creatinine-based (EKFC-eGFRcr), Cys-based (EKFC-eGFRcys), and the combined (EKFC-eGFRcrcys) model - for predicting all-cause and cardiovascular (CV) mortality.

methodsWe analyzed a population-based cohort of 4,519 participants from the National Health and Nutrition Examination Survey (NHANES) 1999-2002. eGFR was calculated using all three EKFC variations (EKFC-eGFRcr, EKFC-eGFRcys, and EKFC-eGFRcrcys). The primary and secondary endpoints were all-cause and CV mortality, respectively, through December 31, 2019. Predictive improvements were evaluated using integrated discrimination improvement (IDI), net reclassification improvement (NRI), and number needed to measure (NNM).

resultsThe eGFR value calculated by the EKFC-eGFRcys, EKFC-eGFRcr, and EKFC-eGFRcrcys was 78.92 ± 22.98, 84.45 ± 23.21, and 81.68 ± 22.13 mL/min/1.73 m2, respectively. Over a median follow-up of 211 months, all three eGFR models were independent predictors of mortality (all p < 0.001). Restricted cubic spline regression revealed significant non-linear, inverse associations between all eGFR measures and adjusted mortality risks (all p for non-linearity < 0.001). Compared to EKFC-eGFRcr, EKFC-eGFRcys significantly improved risk reclassification for all-cause mortality (categorical NRI = 15.9%; 95% CI: 14.1-17.8%; NNM = 7). The combined EKFC-eGFRcrcys also outperformed the Cr-only model (NRI = 8.9%; NNM = 12). However, EKFC-eGFRcys demonstrated modestly better performance than the combined equation (NRI = 7.0%; NNM = 15), suggesting limited incremental value in adding Cr to Cys. The superiority of EKFC-eGFRcys was primarily driven by improved classification of non-events.

conclusionThe EKFC-eGFRcys equation provides superior prognostic value for all-cause and CV mortality compared to both Cr-based and combined EKFC equations. Notably, the combined model offered no prognostic advantage over Cys alone. These findings highlight the clinical importance of Cys-based eGFR for accurate risk stratification in the general population.

Indexed as

Cardiovascular DiseasesCreatinineCystatin CGlomerular Filtration RateRenal Insufficiency, ChronicAgedCause of DeathCohort StudiesEuropeFemaleHumansKidney Function TestsMaleMiddle AgedNutrition SurveysPredictive Value of TestsCreatinineCystatin CCardio-renal syndromeChronic kidney diseaseCystatin CEuropean Kidney Function Consortium equationMortality predictionPopulation-based cohort studySerum creatinine

Identifiers

PMID42263037
PMCPMC13432935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.